Signifor (pasireotide)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Signifor (pasireotide), covering 2018-06-19 to 2024-08-28. Get the full timeline:
Most recent: Clinical Trial Update: Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies [Phase 4]